key: cord-0882823-ujrw3rxb
authors: Imamura, Teruhiko
title: Optimal Management of Thrombotic Complications in Patients With Coronavirus Disease 2019
date: 2021-05-28
journal: Crit Care Med
DOI: 10.1097/ccm.0000000000005178
sha: eda2d37864bcf8ee5d931c8821d434d41233651c
doc_id: 882823
cord_uid: ujrw3rxb

nan

The authors could not find any baseline characteristics including coagulopathyrelated biomarkers that predicted thrombotic complications (2) . In their definition, all thrombotic complications were counted as end points. How about investigating factors associating with severe or fatal thrombotic complications, instead of all thrombotic complications? They should be the end point that we want to predict.

In their study, the patients with thrombotic complications had a higher prevalence of mortality (2) . The next concern is causality: whether the thrombotic complications themselves were directly associated with death or the severity of coronavirus disease 2019 and comorbidities were associated with death (1). Causes of death and multivariate analyses adjusting for baseline characteristics would approach this concern. Several patients seem to have received repeated image assessments (2) . Additional analyses to investigate the prognostic impact of improvement in thrombotic complications would clarify the implication of aggressive intervention to the thrombotic complications.

Reasons for the Overuse of Sedatives and Deep Sedation for Mechanically Ventilated Coronavirus Disease

Coagulopathy in COVID-19

Prevalence of thrombotic complications in ICUtreated patients with coronavirus disease 2019 detected with systematic CT scanning